Production (Stage)
BioScience Health Innovations, Inc.
BHIC
$9.01
-$0.99-9.90%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 426.80K | 10.00K | 56.20K | 74.20K | -53.40K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -98.50K | -60.30K | -4.00K | -4.90K | 5.30K |
| Cash from Operations | 328.30K | -50.30K | 52.20K | 69.30K | -48.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -30.00K | -19.00K | -7.00K | -- | -- |
| Cash from Investing | -30.00K | -19.00K | -7.00K | -- | -- |
| Total Debt Issued | 589.50K | 270.10K | 274.30K | 185.60K | 232.80K |
| Total Debt Repaid | -522.00K | -326.50K | -255.20K | -203.90K | -286.10K |
| Issuance of Common Stock | -- | 455.00K | 125.00K | 0.00 | 175.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 67.50K | 398.60K | 144.10K | -18.30K | 121.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 365.80K | 329.30K | 189.30K | 51.00K | 73.70K |